News Vivozon Pharmaceutical Co., Ltd.

Equities

A082800

KR7082800004

End-of-day quote Korea S.E. Other stock markets 03:30:00 16/05/2024 am IST			5-day change	1st Jan Change
2,840 ^KRW	-0.18%		-1.73%	-5.33%

2023	Tranche Update on Vivozon Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	CI
2023	Vivozon Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 5,000,000 shares.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Vivozon Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	21/23/21	CI
Vivozon Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 5,000,000 shares.	20/23/20	CI
Vivozon Pharmaceutical Co., Ltd. announces an Equity Buyback for 5,000,000 shares.	19/23/19	CI
Vivozon Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	19/23/19	CI
Vivozon Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Vivozon Pharmaceutical Co., Ltd. announced that it has received KRW 2.000000072 billion in funding	28/23/28	CI
Vivozon Pharmaceutical Co., Ltd. announced that it expects to receive KRW 2.000000072 billion in funding	09/23/09	CI
Vivozon Pharmaceutical Co., Ltd. announced that it has received KRW 6 billion in funding	20/22/20	CI
Vivozon Healthcare, Inc. announced that it expects to receive KRW 6 billion in funding	11/22/11	CI
Vivozon Healthcare, Inc.(KOSDAQ:A082800) dropped from S&P Global BMI Index	26/22/26	CI
Vivozon Healthcare, Inc. announced that it has received KRW 58.171164251 billion in funding from Vaultea, Inc. and other investors	05/22/05	CI
Vivozon Healthcare, Inc. announced that it expects to receive KRW 58.171164251 billion in funding from Vaultea, Inc. and other investors	25/22/25	CI
Vivozon Healthcare, Inc. announced that it has received KRW 10 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd.	17/21/17	CI
Vivozon Healthcare, Inc. announced that it expects to receive KRW 10 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd.	10/21/10	CI
Osung Advanced Materials Co., Ltd. cancelled the acquisition of Rumi Technology & Loan CO.,LTD. from Lumimicro Co., Ltd for KRW 33.7 billion.	17/21/17	CI
December Fund 3, Nikkei Fund 3 and Pureun Fund 1 cancelled the acquisition of 23.85% stake in Lumimicro Co., Ltd from Osung Advanced Materials Co., Ltd. and S-MAC CO., Ltd..	18/20/18	CI
Vivozon Healthcare, Inc. announced that it has received KRW 30 billion in funding from Korea Fixed-Income Investment Advisory, Korea Bond Investment Advisory Co., Ltd.	05/20/05	CI
Lumimicro Co., Ltd completed the acquisition of 85.78% stake in Inist Bio Co.,Ltd. from Inistpharm Co.,Ltd, Kim, Kook-Hyun, Park, Ji-seop, Industrial Bank of Korea and others.	30/20/30	CI
Lumimicro Co., Ltd agreed to acquire 85.78% stake in Inist Bio Co.,Ltd. from Inistpharm Co.,Ltd, Kim, Kook-Hyun, Park, Ji-seop, Industrial Bank of Korea and others for KRW 60.9 billion.	23/20/23	CI
Vivozon Healthcare, Inc.(KOSDAQ:A082800) added to S&P Global BMI Index	21/20/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Vivozon Pharmaceutical Co., Ltd.

Equities

A082800

KR7082800004

Summary

Filters